Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Master Rollover Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)

NCT06174987 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT06174987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06174987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Master Rollover Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)
Lead sponsor
Daiichi Sankyo
Phase
Phase 3
Overall status
Recruiting
Start date
January 5, 2024
Completion date
January 17, 2028
Enrollment
50 (estimated)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, metastatic cancer